SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Drug Combo Tied to Kidney Risk With Some Cardiac Surgeries
February 8, 2008
 · 
1 min read
Drug Development
Diabetes And Cardiovascular Disease Trial Involving Intensively Lower Blood Glucose Stopped For Risk Of Death
February 7, 2008
 · 
1 min read
Drug Development
Blood Pressure Drug Cuts Parkinson’s?
February 7, 2008
 · 
1 min read
Drug Development
Infant Study Casts Doubt on Vaccine-Autism Link; Mercury From Vaccines Disappears Quickly
January 31, 2008
 · 
1 min read
Drug Development
Drug Helps Brain Tumor Patients Live Longer
January 29, 2008
 · 
1 min read
Drug Development
Birth Control Pill Lowers Ovarian Cancer Risk, Oxford University Study
January 25, 2008
 · 
1 min read
Drug Development
Gene Variations Associated With Effectiveness Of Blood Pressure Medications
January 24, 2008
 · 
1 min read
Drug Development
Cholesterol-Lowering Drugs May Not Prevent Alzheimer’s Disease
January 17, 2008
 · 
1 min read
Drug Development
Hormones Raise Breast Cancer Risk Quickly
January 15, 2008
 · 
1 min read
Drug Development
Previous Findings Regarding Widely Used Asthma Treatment Challenged
January 14, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Gilead Sciences, Inc.’s Four-in-One AIDS Pill is Effective in Study
March 8, 2012
 · 
7 min read
Drug Development
MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco Diagnostics Inc.’s MultiHance® (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist™ (gadobutrol injection)
March 7, 2012
 · 
1 min read
Drug Development
More Patients Relapse in Gilead Sciences, Inc. Hepatitis C Trial
March 7, 2012
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA), Merck & Co., Inc. Hepatitis Drugs Work in HIV Patients
March 6, 2012
 · 
1 min read
Drug Development
Shire plc to Initiate Two Phase 4 Clinical Trials to Compare Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) to Concerta® (methylphenidate HCl) Extended-Release Tablets, (CII)
March 6, 2012
 · 
10 min read
Drug Development
Genentech’s ACTEMRA® Shows Superiority in Rheumatoid Arthritis Signs and Symptoms Versus Adalimumab
March 2, 2012
 · 
6 min read
Drug Development
Novartis AG Cancer Drugs Fight Deadly Ebola Virus in Lab, Researchers Find
March 1, 2012
 · 
1 min read
Drug Development
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
February 23, 2012
 · 
1 min read
Drug Development
Roche’s Zelboraf May Double Survival for Some Melanoma Patients
February 23, 2012
 · 
1 min read
Drug Development
European Medicines Evaluation Agency Recommends Lifting Suspension of Bayer HealthCare’s Trasylol
February 21, 2012
 · 
1 min read
Drug Development
SCOLR Pharma, Inc.'s Partner to Commence Bioequivalence Study of Ondansetron
February 15, 2012
 · 
3 min read
Drug Development
FDA, Merck & Co., Inc. Warn Against Using Victrelis With Some HIV Drugs
February 10, 2012
 · 
1 min read
Drug Development
Eisai Company, Ltd.'s Cancer Drug Reverses Alzheimer’s Symptoms
February 10, 2012
 · 
1 min read
Drug Development
BioSante Pharmaceuticals, Inc. Reports Positive LibiGel®Safety Data Review for Phase III Program
February 9, 2012
 · 
7 min read
Drug Development
Merck & Co., Inc. Rotavirus Vaccine Not Linked to Bowel Problems in Study
February 8, 2012
 · 
1 min read
Drug Development
Pfizer Inc.'s Breast-Cancer Drug Worsens Bone Loss in Older Women
February 7, 2012
 · 
1 min read
Drug Development
American Stroke Association Release: Warfarin and Aspirin are Similar in Heart Failure Treatment
February 3, 2012
 · 
1 min read
Drug Development
American Stroke Association Release: Clopidogrel With Aspirin Doesn’t Prevent More Small Strokes, May Increase Risk of Bleeding, Death
February 3, 2012
 · 
1 min read
Drug Development
Gilead Sciences, Inc. Soars on Positive Data From Experimental Hepatitis C Drug; Stock Rises +4.77(9.68%) @ 1:09PM EST
February 3, 2012
 · 
1 min read
Drug Development
AB Science Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as Compared to Pfizer Inc.'s Sutent®in Gleevec®-resistant GIST
February 1, 2012
 · 
4 min read
Load More